Equipalazone Original 1 g oral powder (box of 100) POM-V

Product Description

Description Equipalazone Original 1 g oral powder

Active substance: Phenylbutazone 1 g Excipients: Qualitative composition of excipients and other constituents Acacia Gelatin Silicon dioxide White/cream powder.

Intended use Horses and ponies (non-food producing).

3.2 Indications for use for each target species For the treatment of musculoskeletal disorders in horses and ponies where the antiinflammatory and analgesic properties of phenylbutazone can offer relief. Examples of conditions normally considered suitable for treatment with phenylbutazone include lameness associated with osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis, and in the reduction of post-surgical soft tissue reaction.

3.3 Contraindications Do not administer with other non-steroidal anti-inflammatory drugs (NSAIDs) concurrently or within 24 hours of each other. Do not use in animals suffering from cardiac, hepatic or renal disease; where there is the possibility of gastrointestinal ulceration or bleeding; or where there is evidence of a blood dyscrasia. Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

Administration routes and dosage Oral use. When mixed with a concentrate feed, the veterinary medicinal product was shown to be palatable to horses. The dosage should be adjusted according to the individual animal’s response, but the following may be taken as a guide: Horses 450 kg (1000 lb) body weight: the contents of two sachets to be administered twice on day 1 of treatment (equivalent to 8.8 mg/kg/day) followed by the contents of one sachet twice daily for four days (4.4 mg/kg/day), then one sachet daily, or on alternate days, sufficient to keep the horse comfortable (2.2 mg/kg/day). Ponies 225 kg (500 lb) body weight, one sachet (4.4 mg/kg) on alternate days. Discontinue treatment if no response is evident after four to five days treatment. For ease of administration mix the powder with a small quantity of feed. Dampening of the veterinary medicinal product in feed 5 minutes prior to feeding has been shown to have no detrimental influence on the palatability of the veterinary medicinal product. However, the influence of prolonged dampening on palatability or stability of the veterinary medicinal product is not known

Withdrawal periods Not authorised for use in horses intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation

View other products in Products »